Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $6.11 | Prev. Close $6.11 | Circuit Range N/A |
Day Range $6.11 - $6.11 | Year Range $0.91 - $16.34 | Volume 109 |
Average Traded $6.11 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jan-26 | $6.09 | $5.93 | -1.00% |
20-Jan-26 | $6.06 | $6.00 | -6.84% |
16-Jan-26 | $6.37 | $6.43 | -0.08% |
15-Jan-26 | $6.20 | $6.44 | +12.78% |
14-Jan-26 | $5.88 | $5.71 | -7.00% |
13-Jan-26 | $6.26 | $6.14 | -6.69% |
12-Jan-26 | $6.71 | $6.58 | -5.05% |